Altitude Lab will relocate its accelerator and startup community to Portal Innovations at Woodbine Labs, combining Utah's established biotech accelerator with new laboratory infrastructure, graduate ...

Box ManipulationIn the history of artificial intelligence and machine learning, the determination of internal parameters ...

Recursion Pharmaceuticals (NASDAQ:RXRX) reported updated clinical data for its investigational treatment for familial ...

Portal Innovations, a venture development platform supporting early-stage life sciences companies, today announced a strategic partnership with Altitude Lab to strengthen the resources available to ...

Together AI builds an agentic compiler to try and bring recursive self improvement capabilities to open source models.

The generosity of strangers has long powered online communities. Spaces like Stack Overflow, GitHub, curl, OpenSSL, Wikipedia ...

Recursion Pharmaceuticals RXRX reported a loss of 22 cents per share in the third quarter of 2026, narrower than the Zacks ...

Recursion said it expects to launch its first registrational trial in the second half of this year for its lead candidate REC-4881 based on talks with the FDA, after the oral familial adenomatous ...

Management is implementing a disciplined capital allocation strategy, lowering 2026 cash operating expense guidance to $375 million and projecting a further reduction to under $360 million in 2027.

Recursion Q3 2026 earnings: clinical wins for REC-4881 and REC-1245, Sanofi progress, and cash runway to 2029.

On November 2, 2026, four researchers including Rikiya Takehi from MIT CSAIL (Computer Science and Artificial Intelligence ...

Alphabet Inc. is rated a Buy due to rapid progress in its Gemini Enterprise and TPU system sales businesses. Read more on ...